Drug intelligence / Profile preview

dextromethorphan + phenylephrine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Dextromethorphan + phenylephrine is an oral combination pharmaceutical product used primarily for the **temporary relief of cough and nasal congestion** associated with the common cold, flu, and upper respiratory tract infections. - **Dextromethorphan** is a non-opioid antitussive (cough suppressant) that acts centrally on the cough center in the medulla oblongata to reduce the cough reflex, without the analgesic or addictive properties associated with opioid cough suppressants. - **Phenylephrine** is a sympathomimetic decongestant that acts as an alpha-1 adrenergic receptor agonist, causing vasoconstriction in nasal mucosa to decrease swelling and congestion. This combination does not treat the underlying infection or cause of symptoms, but provides symptomatic relief. It is available over-the-counter in various formulations, sometimes as part of multi-ingredient cough/cold preparations[5][8].

02

Targets

ADRA1B (α1B)ADRA1D (α1D)DRD (Dopamine receptors)NMDAR (Glutamate receptor ionotropic, NMDA)SERT (Sodium-dependent serotonin transporter)SIGMAR1 (Sigma non-opioid intracellular receptor 1)ADRA1A (α1A)

Beyond the preview

Go deeper on dextromethorphan + phenylephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dextromethorphan + phenylephrine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call